A first-class contract development and manufacturing organization (CDMO), Rottendorf Pharma has been manufacturing, packaging, developing formulations and analytical methods for solid oral dosage forms for the global pharmaceutical industry for more than 85 years. The company produces more than 600 originator and generic drug products annually for big, small, virtual, and global pharmaceutical and biotechnology companies. 

Rottendorf Pharma operates by the philosophy of Total Process Ownership (TPO) and Total Technological Mastering (TTM), in which we work as an extension of clients'​ organizations. Therefore leveraging our expertise to optimize solid dosage form production for our customers'​ benefit. Rottendorf Pharma has neither their own product brands in the market nor holds any product licenses, and therefore is never in competition with their clients. 


Health Care

Biotechnology

Rottendorf Pharma

Markus Krellmann

Björn Stengel

Anke Spreen

Daniel Paul

Valery Hildebrand

Lukas Sikucinski

Dr. Ines Brandherm

Markus Penassa

Niklas Uhlenbrock

Marco Niemann

Matthias Bali

Daniel Niedieker

Julia Böhm

Maren Schmidt

Dr. Jennifer Look

Gregor Wilhelm Sure

Peter Dr. Weber

Jennifer Demandt

Jelena Markovic

Leonhard D.

Judith Uhlenbrock

The Business Development and Management team at Rottendorf Pharma focuses on fostering client relationships, identifying growth opportunities, and managing the seamless transfer of projects and products. They work to align the company's capabilities with client needs, ensuring successful partnerships and optimizing production processes in accordance with Rottendorf's TPO and TTM philosophy. This team plays a pivotal role in expanding the company's footprint in the pharmaceutical contract development and manufacturing sector.

Business Development and Management

Quality Assurance and Control

Management

Business Development and Management

About

Team members

Other teams at Rottendorf Pharma

Quality Assurance and Control

Management